|
Market Closed -
Nasdaq
00:00:00 30/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1760 USD | -1.12% |
|
-35.95% | -89.07% |
| Market Cap | 1.72M 1.51M 1.43M 1.3M 2.44M 165M 2.46M 17.18M 6.62M 84.06M 6.44M 6.3M 271M | P/E 2026 * |
-0.19x | P/E 2027 * | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.72M 1.51M 1.43M 1.3M 2.44M 165M 2.46M 17.18M 6.62M 84.06M 6.44M 6.3M 271M | EV / Sales 2026 * |
0.11x | EV / Sales 2027 * | 0.07x |
| Free-Float |
85.98% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NXGL | Delayed | |
CBOE
| NXGL | Real-time |
Last Transcript: NEXGEL, Inc.
| 1 day | -1.12% | ||
| 1 week | -35.95% | ||
| Current month | -50.95% | ||
| 1 month | -50.00% | ||
| 3 months | -66.30% | ||
| 6 months | -73.33% | ||
| Current year | -89.07% |
| 1 week | 0.16 |  | 0.28 |
| 1 month | 0.16 | | 0.38 |
| Current year | 0.16 | | 1.9 |
| 1 year | 0.16 | | 2.89 |
| 3 years | 0.16 | | 5.1 |
| 5 years | 0.16 | | 5.1 |
| 10 years | 0.16 | | 5.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Kieser
CEO | Chief Executive Officer | 59 | 21/08/2026 |
Ian Blackman
DFI | Director of Finance/CFO | 58 | 27/04/2026 |
Gregory J. Robb
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jerome Zeldis
BRD | Director/Board Member | 76 | 01/04/2020 |
Steven Glassman
CHM | Chairman | 61 | - |
| Director/Board Member | 55 | 31/07/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.12% | -35.95% | -92.74% | -91.70% | 1.72M | |
| -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | |
| -1.61% | -0.60% | +47.32% | +71.79% | 645B | |
| -1.12% | -0.72% | +17.98% | +76.63% | 465B | |
| +0.93% | -2.89% | +35.71% | +42.19% | 335B | |
| +1.18% | +3.95% | +22.09% | +30.92% | 275B | |
| +0.46% | +0.47% | +11.68% | +14.05% | 255B | |
| +1.32% | +3.27% | +54.63% | +57.63% | 229B | |
| -0.61% | -0.91% | +34.33% | +101.87% | 188B | |
| -0.25% | -0.28% | -27.01% | -60.50% | 169B | |
| Average | +0.27% | -3.71% | +16.70% | +36.34% | 361.62B | |
| Weighted average by Cap. | +0.41% | +0.24% | +38.96% | +71.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.79M 13.93M 13.18M 11.95M 22.41M 1.51B 22.63M 158M 60.95M 774M 59.28M 57.99M 2.49B | 24.27M 21.42M 20.26M 18.38M 34.45M 2.33B 34.79M 243M 93.68M 1.19B 91.12M 89.14M 3.83B |
| Net income | -8.33M -7.35M -6.95M -6.31M -11.82M -799M -11.94M -83.41M -32.15M -408M -31.27M -30.59M -1.31B | -2.31M -2.04M -1.93M -1.75M -3.28M -222M -3.31M -23.16M -8.93M -113M -8.68M -8.49M -365M |
| Net Debt | - | - |
Employees
19
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | $0.1760 | -1.12% | 300,069 |
| 28/09/26 | $0.1780 | +2.30% | 767,796 |
| 25/09/26 | $0.1740 | -33.59% | 3,671,536 |
| 24/09/26 | $0.2620 | -2.31% | 334,027 |
| 23/09/26 | $0.2682 | -2.40% | 117,451 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.1760
Average target price
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NXGL Stock
Select your edition
All financial news and data tailored to specific country editions
